Virtual Reality ter pijnverlichting bij hysterosalpingografie
Recruiting
- Conditions
- Infertility / tubal pathology
- Registration Number
- NL-OMON28038
- Lead Sponsor
- Amsterdam UMC
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- Not specified
- Target Recruitment
- 134
Inclusion Criteria
Women who:
-Will undergo an HSG with oil-based contrast for infertility
-Have no history of cervical procedures
-Speak Dutch or English
Exclusion Criteria
Women who:
-Are on chronic pain medication
-Use antidepressants or sedatives
-Underwent an HSG before
-Are unwilling or unable to give ‘informed consent’
-Are pregnant
-Have a malignancy
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method The primary endpoint is pain during the HSG. This measure consists of two components: the most severe pain (using a visual analogue scale 0-10) and the overall pain (using a visual analogue scale 0-10)
- Secondary Outcome Measures
Name Time Method Secondary endpoints are: <br>-(Hypothetical) willingness to undergo another HSG if necessary<br>-Use of oral analgesics during the first 24 hours after the HSG<br>-‘Immersiveness’ in the VR program<br>-Side effects of the VR program <br>